44 results
Page 2 of 3
6-K
EX-99.1
0gkaaw
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
ele5ezithc
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.1
j5aa8e2g9e3
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
ng4yf
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
i63bofeyimux85ud 5ug
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
g8v8gt qbfp
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
c06o1po1kv mdz8j
18 Dec 20
Draft registration statement
12:00am
6-K
EX-10.1
xa3naz9p
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
pfpmbk9s
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
424B4
x34dg90kwx6jdt
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
syoksh e81qs
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.7
q1jer sel99p
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.5
l5sh 28lxt43k4x
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-2.2
7dq6g96vxeq3g7vsg
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.3
ruup9xm3 ilk
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.1
v32fhf1xagnqc 1bl
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.2
mq3fgjijpi6fzdprkd
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
gm7obs v4p
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
oa6oq170l63yz
29 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
qdflhg 2mj
11 May 20
Draft registration statement (amended)
12:00am